Health

Pharmaceutical Influence on FDA Panels

Updated 2026-10-13 18:10 UTC 1 source Negative

Analysis reveals that nearly 40% of patient and consumer representatives on FDA advisory panels have active ties to advocacy groups funded by pharmaceutical companies, raising concerns about potential conflicts of interest.

Coverage timeline — 1 article

STAT News

STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds

Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.

2026-10-13 18:00 UTC